Cargando…
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy
Fibroblast growth factor receptor 2 (FGFR2) is a membrane‐spanning tyrosine kinase that mediates FGF signaling. Various FGFR2 alterations are detected in breast cancer, yet it remains unclear if activation of FGFR2 signaling initiates tumor formation. In an attempt to answer this question, a mouse m...
Autores principales: | Lei, Josh Haipeng, Lee, Mi‐Hye, Miao, Kai, Huang, Zebin, Yao, Zhicheng, Zhang, Aiping, Xu, Jun, Zhao, Ming, Huang, Zenan, Zhang, Xin, Chen, Si, Jiaying, NG, Feng, Yuzhao, Xing, Fuqiang, Chen, Ping, Sun, Heng, Chen, Qiang, Xiang, Tingxiu, Chen, Lin, Xu, Xiaoling, Deng, Chu‐Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564435/ https://www.ncbi.nlm.nih.gov/pubmed/34514747 http://dx.doi.org/10.1002/advs.202100974 |
Ejemplares similares
-
Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing
por: Sun, Heng, et al.
Publicado: (2021) -
BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis
por: Chen, Qiang, et al.
Publicado: (2020) -
BRCA1 Deficiency: BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis (Adv. Sci. 6/2020)
por: Chen, Qiang, et al.
Publicado: (2020) -
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
por: Miao, Kai, et al.
Publicado: (2020) -
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
por: Li, Jianjie, et al.
Publicado: (2022)